Australia's Imugene eyes record weekly gain on cancer-killing virus study

Imugene

10/11/2023 24:52

** Shares of clinical stage immuno-oncology co Imugene Ltd
 IMU.AX  rise as much as 36.4% to A$0.150, their highest since
April 20
    ** IMU set to gain nearly 176% for the week, its best weekly
gain ever
    ** On Monday, co flagged positive early signs from its
early-stage study testing efficacy of cancer-killing virus
VAXINIA
    ** Stock up for a seventh consecutive session
    ** IMU top gainer on the ASX All Ordinaries Index  .AORD 
    ** About 120.7 mln shares change hands, 2.6 times the 30-day
average of 45.8 mln shares
    ** As of last close, stock down 24.1% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))